Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 08/02/2018, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39966a ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Stomach Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ecansya (previously Capecitabine Krka), capecitabine, Colonic Neoplasms,Breast Neoplasms,Colorectal Neoplasms,Stomach Neoplasms, Date of authorisation: 19/04/2012, Revision: 9, Status: Authorised

Case Medical Research ◽

10.31525/cmr-3996c4 ◽

2018 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Colorectal Neoplasms ◽

Stomach Neoplasms ◽

Colonic Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Taxespira (previously Docetaxel Hospira UK Limited ), docetaxel, Stomach Neoplasms,Prostatic Neoplasms,Breast Neoplasms,Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung, Date of authorisation: 28/08/2015, Revision: 8, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-1f52484 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Stomach Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 26/07/2018, Revision: 3, Status: Authorised

Case Medical Research ◽

10.31525/cmr-12154e1 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Stomach Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 08/02/2018, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-bd64ab ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Stomach Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ecansya (previously Capecitabine Krka), capecitabine, Colonic Neoplasms,Breast Neoplasms,Colorectal Neoplasms,Stomach Neoplasms, Date of authorisation: 20/04/2012, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-20647ff ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Colorectal Neoplasms ◽

Stomach Neoplasms ◽

Colonic Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Xeloda, capecitabine, Colonic Neoplasms,Breast Neoplasms,Colorectal Neoplasms,Stomach Neoplasms, Date of authorisation: 02/02/2001, Revision: 24, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1b537e9 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Colorectal Neoplasms ◽

Stomach Neoplasms ◽

Colonic Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Capecitabine Accord, capecitabine, Colonic Neoplasms,Breast Neoplasms,Colorectal Neoplasms,Stomach Neoplasms, Date of authorisation: 20/04/2012, Revision: 9, Status: Authorised

Case Medical Research ◽

10.31525/cmr-3996a8 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Colorectal Neoplasms ◽

Stomach Neoplasms ◽

Colonic Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 28/08/2000, Revision: 36, Status: Authorised

Case Medical Research ◽

10.31525/cmr-13b88df ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Stomach Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ontruzant, trastuzumab, Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 15/11/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871a2 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Stomach Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Capecitabine Teva, capecitabine, Colonic Neoplasms,Breast Neoplasms,Colorectal Neoplasms,Stomach Neoplasms, Date of authorisation: 20/04/2012, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1740560 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Colorectal Neoplasms ◽

Stomach Neoplasms ◽

Colonic Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text